MoneyWorks4Me

Valiant Laboratories - Quaterly Results

20 May 2025 Evaluate
The Top line for the quarter ended March 2025 of Rs. 577.70 millions up 88.90% from Rs. 305.83 millions.The Total Profit for the quarter ended March 2025 of Rs. 32.38 millions grew from Rs.-12.17 millions Operating profit Margin for the quarter ended March 2025 improved to 44.83% as compared to -20.27% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 577.70 305.83 88.90 1333.62 1820.52 -26.75 1333.62 1820.52 -26.75
Other Income 6.54 25.03 -73.87 54.28 96.82 -43.94 54.28 96.82 -43.94
PBIDT 44.83 -20.27 -321.16 7.53 12.73 -40.85 7.53 12.73 -40.85
Interest 0.55 0.21 161.90 1.75 0.78 124.36 1.75 0.78 124.36
PBDT 44.28 -20.48 -316.21 5.78 11.95 -51.63 5.78 11.95 -51.63
Depreciation 5.05 5.02 0.60 20.25 19.48 3.95 20.25 19.48 3.95
PBT 39.23 -25.50 -253.84 -14.47 -7.53 92.16 -14.47 -7.53 92.16
TAX 6.85 -13.33 -151.39 7.02 -10.93 -164.23 7.02 -10.93 -164.23
Deferred Tax 6.28 2.46 155.28 6.46 -1.11 -681.98 6.46 -1.11 -681.98
PAT 32.38 -12.17 -366.06 -21.49 3.40 -732.06 -21.49 3.40 -732.06
Equity 434.50 434.50 0.00 434.50 434.50 0.00 434.50 434.50 0.00
PBIDTM(%) 7.76 -6.63 -217.08 0.56 0.70 -19.26 0.56 0.70 -19.26
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..